{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:56:32Z","timestamp":1790841392324,"version":"4.1.0"},"reference-count":348,"publisher":"The Royal Society","issue":"1960","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ageing is a primary risk factor for neurodegenerative disorders, including Parkinson's disease (PD). As individuals age, their cells become less efficient in maintaining protein homeostasis, leading to an increased likelihood of protein misfolding and aggregation. A hallmark of PD and other synucleinopathies is the accumulation of alpha-synuclein protein aggregates in affected neurons, a process that is exacerbated by ageing. While cellular mechanisms that regulate protein aggregation have been a primary focus of research, recent studies suggest that other, systemic age-related mechanisms may contribute to alpha-synuclein toxicity. Understanding these alternative pathways is crucial for the development of effective therapeutic strategies to combat neurodegenerative diseases, such as PD. In this review, we synthesize current insights into the biological mechanisms underlying alpha-synuclein toxicity at the organismal level. We highlight key open questions and discuss how these findings may inform the development of targeted interventions to prevent or delay age-related synucleinopathies.<\/jats:p>\n                  <jats:p>This article is part of the Theo Murphy meeting issue \u2018ProteostaSys: a systems view of proteostasis\u2019.<\/jats:p>","DOI":"10.1098\/rstb.2025.0275","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:08:22Z","timestamp":1790838502000},"source":"Crossref","is-referenced-by-count":0,"title":["Cellular and systemic modifiers of alpha-synuclein proteostasis"],"prefix":"10.1098","volume":"381","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1449-9637","authenticated-orcid":false,"given":"Suzanne","family":"Couzijn","sequence":"first","affiliation":[{"name":"European Research Institute for the Biology of Ageing (ERIBA), University Medical Centre Groningen (UMCG) , 9713AV Groningen, GR, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4209-0150","authenticated-orcid":false,"given":"Anna P.","family":"Ainslie","sequence":"additional","affiliation":[{"name":"European Research Institute for the Biology of Ageing (ERIBA), University Medical Centre Groningen (UMCG) , 9713AV Groningen, GR, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2403-6345","authenticated-orcid":false,"given":"Alejandro","family":"Herron-Bedoya","sequence":"additional","affiliation":[{"name":"European Research Institute for the Biology of Ageing (ERIBA), University Medical Centre Groningen (UMCG) , 9713AV Groningen, GR, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3740-6373","authenticated-orcid":false,"given":"Ellen A. A.","family":"Nollen","sequence":"additional","affiliation":[{"name":"European Research Institute for the Biology of Ageing (ERIBA), University Medical Centre Groningen (UMCG) , 9713AV Groningen, GR, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"175","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"2026100103081524800_RSTB20250275C1","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.3390\/ijms26115405","article-title":"\u03b1-synuclein pathology in synucleinopathies: mechanisms, biomarkers, and therapeutic challenges","volume":"26","author":"Arias-Carri\u00f3n","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"2026100103081524800_RSTB20250275C2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis."},{"key":"2026100103081524800_RSTB20250275C3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0896-6273(95)90040-3","article-title":"Characterization of a novel protein regulated during the critical period for song learning in the zebra finch","volume":"15","author":"George","year":"1995","journal-title":"Neuron"},{"key":"2026100103081524800_RSTB20250275C4","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","article-title":"Stabilization of \u03b1-synuclein secondary structure upon binding to synthetic membranes","volume":"273","author":"Davidson","year":"1998","journal-title":"J. Biol. Chem."},{"key":"2026100103081524800_RSTB20250275C5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41594-020-0384-x","article-title":"A short motif in the N-terminal region of \u03b1-synuclein is critical for both aggregation and function","volume":"27","author":"Doherty","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2026100103081524800_RSTB20250275C6","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1074\/jbc.M008919200","article-title":"A hydrophobic stretch of 12 amino acid residues in the middle of \u03b1-synuclein is essential for filament assembly","volume":"276","author":"Giasson","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2026100103081524800_RSTB20250275C7","doi-asserted-by":"crossref","first-page":"9427","DOI":"10.1021\/bi900539p","article-title":"Characterization of hydrophobic residue requirements for \u03b1-synuclein fibrillization","volume":"48","author":"Waxman","year":"2009","journal-title":"Biochemistry"},{"key":"2026100103081524800_RSTB20250275C8","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41467-018-03111-4","article-title":"C-terminal calcium binding of \u03b1-synuclein modulates synaptic vesicle interaction","volume":"9","author":"Lautenschl\u00e4ger","year":"2018","journal-title":"Nat. Commun."},{"key":"2026100103081524800_RSTB20250275C9","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/s41556-024-01451-6","article-title":"VAMP2 regulates phase separation of \u03b1-synuclein","volume":"26","author":"Agarwal","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"2026100103081524800_RSTB20250275C10","doi-asserted-by":"crossref","first-page":"13 782","DOI":"10.1021\/bi026284c","article-title":"Structural and functional implications of C-terminal regions of \u03b1-synuclein","volume":"41","author":"Kim","year":"2002","journal-title":"ACS Biochemistry"},{"key":"2026100103081524800_RSTB20250275C11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature10324","article-title":"\u03b1-synuclein occurs physiologically as a helically folded tetramer that resists aggregation","volume":"477","author":"Bartels","year":"2011","journal-title":"Nature"},{"key":"2026100103081524800_RSTB20250275C12","doi-asserted-by":"crossref","first-page":"17 797","DOI":"10.1073\/pnas.1113260108","article-title":"A soluble \u03b1-synuclein construct forms a dynamic tetramer","volume":"108","author":"Wang","year":"2011","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026100103081524800_RSTB20250275C13","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","article-title":"Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal","volume":"8","author":"Maroteaux","year":"1988","journal-title":"J. Neurosci."},{"key":"2026100103081524800_RSTB20250275C14","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","article-title":"The precursor protein of non-A\u03b2 component of alzheimer's disease amyloid is a presynaptic protein of the central nervous system","volume":"14","author":"Iwai","year":"1995","journal-title":"Neuron"},{"key":"2026100103081524800_RSTB20250275C15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000112832","article-title":"Red blood cells are the major source of alpha-synuclein in blood","volume":"5","author":"Barbour","year":"2008","journal-title":"Neurodegener. Dis."},{"key":"2026100103081524800_RSTB20250275C16","doi-asserted-by":"crossref","first-page":"a024091","DOI":"10.1101\/cshperspect.a024091","article-title":"Cell biology and pathophysiology of \u03b1-synuclein","volume":"8","author":"Burr\u00e9","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2026100103081524800_RSTB20250275C17","doi-asserted-by":"crossref","first-page":"167714","DOI":"10.1016\/j.jmb.2022.167714","article-title":"Functional and pathological effects of \u03b1-synuclein on synaptic SNARE complexes","volume":"435","author":"Gao","year":"2023","journal-title":"J. Mol. Biol."},{"key":"2026100103081524800_RSTB20250275C18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of \u03b1-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."},{"key":"2026100103081524800_RSTB20250275C19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding \u03b1-synuclein in Parkinson's disease","volume":"18","author":"Kr\u00fcger","year":"1998","journal-title":"Nat. Genet."},{"key":"2026100103081524800_RSTB20250275C20","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the \u03b1-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"2026100103081524800_RSTB20250275C21","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"\u03b1-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"key":"2026100103081524800_RSTB20250275C22","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0140-6736(04)17104-3","article-title":"Causal relation between \u03b1-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Ib\u00e1\u00f1ez","year":"2004","journal-title":"Lancet"},{"key":"2026100103081524800_RSTB20250275C23","doi-asserted-by":"crossref","DOI":"10.1126\/science.1090278","article-title":"\u03b1-synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"2026100103081524800_RSTB20250275C24","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1124\/pharmrev.123.001111","article-title":"Posttranslational modifications of \u03b1-synuclein, their therapeutic potential, and crosstalk in health and neurodegenerative diseases","volume":"76","author":"Hassanzadeh","year":"2024","journal-title":"Pharmacol. Rev."},{"key":"2026100103081524800_RSTB20250275C25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41593-022-01239-7","article-title":"Post-translational modifications of soluble \u03b1-synuclein regulate the amplification of pathological \u03b1-synuclein","volume":"26","author":"Zhang","year":"2023","journal-title":"Nat. Neurosci."},{"key":"2026100103081524800_RSTB20250275C26","doi-asserted-by":"crossref","first-page":"690293","DOI":"10.3389\/fnagi.2021.690293","article-title":"Alpha-synuclein post-translational modifications: implications for pathogenesis of Lewy body disorders","volume":"13","author":"Manzanza","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"2026100103081524800_RSTB20250275C27","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/1873-3468.14361","article-title":"\u03b1-synuclein phase separation and amyloid aggregation are modulated by C-terminal truncations","volume":"596","author":"Huang","year":"2022","journal-title":"FEBS Lett."},{"key":"2026100103081524800_RSTB20250275C28","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s42003-022-03768-0","article-title":"C-terminal truncation modulates \u03b1-synuclein's cytotoxicity and aggregation by promoting the interactions with membrane and chaperone","volume":"5","author":"Zhang","year":"2022","journal-title":"Commun. Biol."},{"key":"2026100103081524800_RSTB20250275C29","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/brainsci10040232","article-title":"Do post-translational modifications influence protein aggregation in neurodegenerative diseases: a systematic review","volume":"10","author":"Schaffert","year":"2020","journal-title":"Brain Sci."},{"key":"2026100103081524800_RSTB20250275C30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41531-025-01084-y","article-title":"Differential role of C-terminal truncations on alpha-synuclein pathology and Lewy body formation","volume":"11","author":"Mahul-Mellier","year":"2025","journal-title":"NPJ Parkinson's Dis."},{"key":"2026100103081524800_RSTB20250275C31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/1735-1995.181989","article-title":"Alpha-synuclein structure, functions, and interactions","volume":"21","author":"Emamzadeh","year":"2016","journal-title":"J. Res. Med. Sci."},{"key":"2026100103081524800_RSTB20250275C32","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","article-title":"The function of \u03b1-synuclein","volume":"79","author":"Bendor","year":"2013","journal-title":"Neuron"},{"key":"2026100103081524800_RSTB20250275C33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tins.2022.11.007","article-title":"\u03b1-synuclein in synaptic function and dysfunction","volume":"46","author":"Sharma","year":"2023","journal-title":"Trends Neurosci."},{"key":"2026100103081524800_RSTB20250275C34","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1007\/PL00000671","article-title":"Alpha-synuclein and Parkinson's disease","volume":"57","author":"L\u00fccking","year":"2000","journal-title":"Cell. Mol. Life Sci."},{"key":"2026100103081524800_RSTB20250275C35","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fnins.2019.00328","article-title":"Dysregulated lipid metabolism and its role in \u03b1-synucleinopathy in Parkinson's disease","volume":"13","author":"Alecu","year":"2019","journal-title":"Front. Neurosci."},{"key":"2026100103081524800_RSTB20250275C36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fncel.2019.00175","article-title":"Lipids at the crossroad of \u03b1-synuclein function and dysfunction: biological and pathological implications","volume":"13","author":"Alza","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"2026100103081524800_RSTB20250275C37","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.3390\/ijms21093301","article-title":"Lipids: key players that modulate \u03b1-synuclein toxicity and neurodegeneration in Parkinson's disease","volume":"21","author":"Mori","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"2026100103081524800_RSTB20250275C38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41531-019-0103-7","article-title":"Parkinson's disease: proteinopathy or lipidopathy?","volume":"6","author":"Fanning","year":"2020","journal-title":"NPJ Parkinson's Dis."},{"key":"2026100103081524800_RSTB20250275C39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3233\/JPD-171103","article-title":"The role of lipids interacting with \u03b1-synuclein in the pathogenesis of Parkinson's disease","volume":"7","author":"Galvagnion","year":"2017","journal-title":"J. Parkinson's Dis."},{"key":"2026100103081524800_RSTB20250275C40","doi-asserted-by":"crossref","first-page":"9110","DOI":"10.1073\/pnas.171300598","article-title":"\u03b1-synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins","volume":"98","author":"Sharon","year":"2001","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026100103081524800_RSTB20250275C41","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3389\/fnins.2019.01399","article-title":"Alpha-synuclein physiology and pathology: a perspective on cellular structures and organelles","volume":"13","author":"Bernal-Conde","year":"2020","journal-title":"Front. Neurosci."},{"key":"2026100103081524800_RSTB20250275C42","doi-asserted-by":"crossref","first-page":"10 510","DOI":"10.1523\/JNEUROSCI.1659-16.2016","article-title":"Monomeric alpha-synuclein exerts a physiological role on brain ATP synthase","volume":"36","author":"Ludtmann","year":"2016","journal-title":"J. Neurosci."},{"key":"2026100103081524800_RSTB20250275C43","doi-asserted-by":"crossref","first-page":"7651","DOI":"10.1038\/s41467-025-62895-4","article-title":"Alpha-synuclein interacts with regulators of ATP homeostasis in mitochondria","volume":"16","author":"Serdiuk","year":"2025","journal-title":"Nat. Commun."},{"key":"2026100103081524800_RSTB20250275C44","doi-asserted-by":"crossref","first-page":"E1206","DOI":"10.1073\/pnas.1524128113","article-title":"Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading","volume":"113","author":"Iljina","year":"2016","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026100103081524800_RSTB20250275C45","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1126\/science.1178250","article-title":"An analytical solution to the kinetics of breakable filament assembly","volume":"326","author":"Knowles","year":"2009","journal-title":"Science"},{"key":"2026100103081524800_RSTB20250275C46","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","article-title":"Direct observation of the interconversion of normal and toxic forms of \u03b1-synuclein","volume":"149","author":"Cremades","year":"2012","journal-title":"Cell"},{"key":"2026100103081524800_RSTB20250275C47","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1038\/s41467-018-05971-2","article-title":"Cryo-EM of full-length \u03b1-synuclein reveals fibril polymorphs with a common structural kernel","volume":"9","author":"Li","year":"2018","journal-title":"Nat. Commun."},{"key":"2026100103081524800_RSTB20250275C48","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.tins.2016.09.003","article-title":"\u03b1-synuclein-based animal models of Parkinson's disease: challenges and opportunities in a new era","volume":"39","author":"Visanji","year":"2016","journal-title":"Trends Neurosci."},{"key":"2026100103081524800_RSTB20250275C49","doi-asserted-by":"crossref","first-page":"e1000027","DOI":"10.1371\/journal.pgen.1000027","article-title":"C. elegans model identifies genetic modifiers of \u03b1-synuclein inclusion formation during aging","volume":"4","author":"van Ham","year":"2008","journal-title":"PLoS Genet."},{"key":"2026100103081524800_RSTB20250275C50","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/NEN.0b013e31818c3618","article-title":"Aggregates assembled from overexpression of wild-type \u03b1-synuclein are not toxic to human neuronal cells","volume":"67","author":"Ko","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2026100103081524800_RSTB20250275C51","doi-asserted-by":"crossref","first-page":"15 313","DOI":"10.1074\/jbc.M213128200","article-title":"A broken \u03b1-helix in folded \u03b1-synuclein","volume":"278","author":"Chandra","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2026100103081524800_RSTB20250275C52","doi-asserted-by":"crossref","first-page":"E4274","DOI":"10.1073\/pnas.1416598111","article-title":"\u03b1-synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation","volume":"111","author":"Burr\u00e9","year":"2014","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026100103081524800_RSTB20250275C53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-4159.2007.04764.x","article-title":"Neuropathology, biochemistry, and biophysics of \u03b1-synuclein aggregation","volume":"103","author":"Uversky","year":"2007","journal-title":"J. Neurochem."},{"key":"2026100103081524800_RSTB20250275C54","first-page":"175","volume-title":"Handbook of Clinical Neurology","author":"Lamotte","year":"2023"},{"key":"2026100103081524800_RSTB20250275C55","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"2026100103081524800_RSTB20250275C56","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrm3810","article-title":"The amyloid state and its association with protein misfolding diseases","volume":"15","author":"Knowles","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2026100103081524800_RSTB20250275C57","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev-genet-112618-043527","article-title":"Liquid\u2013liquid phase separation in disease","volume":"53","author":"Alberti","year":"2019","journal-title":"Annu. Rev. Genet."},{"key":"2026100103081524800_RSTB20250275C58","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.jmb.2020.03.004","article-title":"Liquid\u2013liquid phase separation and its mechanistic role in pathological protein aggregation","volume":"432","author":"Babinchak","year":"2020","journal-title":"J. Mol. Biol."},{"issue":"8","key":"2026100103081524800_RSTB20250275C59","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41557-020-0465-9","article-title":"\u03b1-Synuclein aggregation nucleates through liquid\u2013liquid phase separation","volume":"12","author":"Ray","year":"2020","journal-title":"Nature Chemistry"},{"key":"2026100103081524800_RSTB20250275C60","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41565-020-0731-4","article-title":"Biomolecular condensates undergo a generic shear-mediated liquid-to-solid transition","volume":"15","author":"Shen","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"2026100103081524800_RSTB20250275C61","doi-asserted-by":"crossref","first-page":"eaaf4382","DOI":"10.1126\/science.aaf4382","article-title":"Liquid phase condensation in cell physiology and disease","volume":"357","author":"Shin","year":"2017","journal-title":"Science"},{"key":"2026100103081524800_RSTB20250275C62","doi-asserted-by":"crossref","first-page":"167201","DOI":"10.1016\/j.jmb.2021.167201","article-title":"Sequence determinants of the aggregation of proteins within condensates generated by liquid-liquid phase separation","volume":"434","author":"Vendruscolo","year":"2022","journal-title":"J. Mol. Biol."},{"key":"2026100103081524800_RSTB20250275C63","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41580-020-00326-6","article-title":"Biomolecular condensates at the nexus of cellular stress, protein aggregation disease and ageing","volume":"22","author":"Alberti","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2026100103081524800_RSTB20250275C64","first-page":"282","article-title":"Observation of an \u03b1-synuclein liquid droplet state and its maturation into Lewy body-like assemblies","volume":"13","author":"Hardenberg","year":"2021","journal-title":"J. Mol. Cell Biol."},{"key":"2026100103081524800_RSTB20250275C65","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1042\/BJ20111924","article-title":"Toxic prefibrillar \u03b1-synuclein amyloid oligomers adopt a distinctive antiparallel \u03b2-sheet structure","volume":"443","author":"Celej","year":"2012","journal-title":"Biochem. J."},{"key":"2026100103081524800_RSTB20250275C66","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1111\/febs.17244","article-title":"Liquid\u2013liquid phase separation of alpha-synuclein increases the structural variability of fibrils formed during amyloid aggregation","volume":"291","author":"Ziaunys","year":"2024","journal-title":"FEBS J."},{"key":"2026100103081524800_RSTB20250275C67","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jmb.2022.167713","article-title":"Liquid-liquid phase separation of \u03b1-synuclein: a new mechanistic insight for \u03b1-synuclein aggregation associated with Parkinson's disease pathogenesis","volume":"435","author":"Mukherjee","year":"2023","journal-title":"J. Mol. Biol."},{"key":"2026100103081524800_RSTB20250275C68","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1093\/nar\/gkae229","article-title":"Protein G-quadruplex interactions and their effects on phase transitions and protein aggregation","volume":"52","author":"Sahoo","year":"2024","journal-title":"Nucleic. Acids. Res."},{"key":"2026100103081524800_RSTB20250275C69","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1021\/acs.biochem.1c00434","article-title":"Modulating \u03b1-synuclein liquid\u2013liquid phase separation","volume":"60","author":"Sawner","year":"2021","journal-title":"Biochemistry"},{"key":"2026100103081524800_RSTB20250275C70","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat. Med."},{"key":"2026100103081524800_RSTB20250275C71","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3390\/biom13050726","article-title":"Distinct effects of familial Parkinson's disease-associated mutations on \u03b1-synuclein phase separation and amyloid aggregation","volume":"13","author":"Xu","year":"2023","journal-title":"Biomolecules"},{"key":"2026100103081524800_RSTB20250275C72","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1038\/s44318-025-00591-1","article-title":"Ubiquilin-2 liquid droplets catalyze \u03b1-synuclein fibril formation","volume":"44","author":"Takei","year":"2025","journal-title":"EMBO J."},{"key":"2026100103081524800_RSTB20250275C73","doi-asserted-by":"crossref","first-page":"166961","DOI":"10.1016\/j.jmb.2021.166961","article-title":"Synapsin condensates recruit alpha-synuclein","volume":"433","author":"Hoffmann","year":"2021","journal-title":"J. Mol. Biol."},{"key":"2026100103081524800_RSTB20250275C74","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1126\/science.aat5671","article-title":"A liquid phase of synapsin and lipid vesicles","volume":"361","author":"Milovanovic","year":"2018","journal-title":"Science"},{"key":"2026100103081524800_RSTB20250275C75","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1016\/j.celrep.2020.01.092","article-title":"Vesicle clustering in a living synapse depends on a synapsin region that mediates phase separation","volume":"30","author":"Pechstein","year":"2020","journal-title":"Cell Rep."},{"key":"2026100103081524800_RSTB20250275C76","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbrc.2022.02.097","article-title":"Calcium promotes \u03b1-synuclein liquid-liquid phase separation to accelerate amyloid aggregation","volume":"603","author":"Huang","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2026100103081524800_RSTB20250275C77","doi-asserted-by":"crossref","first-page":"101469","DOI":"10.1016\/j.jbc.2021.101469","article-title":"Manganese promotes \u03b1-synuclein amyloid aggregation through the induction of protein phase transition","volume":"298","author":"Xu","year":"2022","journal-title":"J. Biol. Chem."},{"key":"2026100103081524800_RSTB20250275C78","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12035-012-8280-y","article-title":"The Lewy body in Parkinson's disease and related neurodegenerative disorders","volume":"47","author":"Wakabayashi","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"2026100103081524800_RSTB20250275C79","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1440-1789.2007.00803.x","article-title":"The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of \u03b1-synuclein aggregates","volume":"27","author":"Wakabayashi","year":"2007","journal-title":"Neuropathology"},{"key":"2026100103081524800_RSTB20250275C80","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jnen\/62.12.1241","article-title":"Morphogenesis of Lewy bodies: dissimilar incorporation of \u03b1-synuclein, ubiquitin, and p62","volume":"62","author":"Kuusisto","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2026100103081524800_RSTB20250275C81","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.2741\/2973","article-title":"Proteomic identification of novel proteins associated with Lewy bodies","volume":"13","author":"Xia","year":"2008","journal-title":"Front. Biosci."},{"key":"2026100103081524800_RSTB20250275C82","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat. Neurosci."},{"key":"2026100103081524800_RSTB20250275C83","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1016\/j.neuron.2024.06.002","article-title":"Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of \u03b1-synuclein inclusions","volume":"112","author":"Lam","year":"2024","journal-title":"Neuron"},{"key":"2026100103081524800_RSTB20250275C84","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/JPD-230183","article-title":"Defining a Lewy body: running up the hill of shifting definitions and evolving concepts","volume":"14","author":"Moors","year":"2024","journal-title":"J.Parkinson's Dis."},{"key":"2026100103081524800_RSTB20250275C85","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1242\/jcs.180737","article-title":"Ca2+ is a key factor in \u03b1-synuclein-induced neurotoxicity","volume":"129","author":"Angelova","year":"2016","journal-title":"J. Cell Sci."},{"key":"2026100103081524800_RSTB20250275C86","first-page":"E1994","article-title":"Structural characterization of toxic oligomers that are kinetically trapped during \u03b1-synuclein fibril formation","volume":"112","author":"Chen","year":"2015","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026100103081524800_RSTB20250275C87","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/s41467-019-09477-3","article-title":"Different soluble aggregates of A\u03b242 can give rise to cellular toxicity through different mechanisms","volume":"10","author":"De","year":"2019","journal-title":"Nat. Commun."},{"key":"2026100103081524800_RSTB20250275C88","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.aan6160","article-title":"Structural basis of membrane disruption and cellular toxicity by \u03b1-synuclein oligomers","volume":"358","author":"Fusco","year":"2017","journal-title":"Science"},{"key":"2026100103081524800_RSTB20250275C89","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1042\/EBC20160008","article-title":"Shape matters: the complex relationship between aggregation and toxicity in protein-misfolding diseases","volume":"60","author":"Ries","year":"2016","journal-title":"Essays Biochem."},{"key":"2026100103081524800_RSTB20250275C90","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3109\/10409238.2014.914151","article-title":"Defining the limits: protein aggregation and toxicity in vivo","volume":"49","author":"Holmes","year":"2014","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"2026100103081524800_RSTB20250275C91","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/biom5020282","article-title":"Seeking a mechanism for the toxicity of oligomeric \u03b1-synuclein","volume":"5","author":"Roberts","year":"2015","journal-title":"Biomolecules"},{"key":"2026100103081524800_RSTB20250275C92","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bpc.2013.06.003","article-title":"The amyloid-cell membrane system","volume":"182","author":"Cecchi","year":"2013","journal-title":"Biophys. Chem."},{"key":"2026100103081524800_RSTB20250275C93","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1089\/ars.2015.6343","article-title":"Alpha-synuclein oligomers interact with metal ions to induce oxidative stress and neuronal death in Parkinson's disease","volume":"24","author":"Deas","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"2026100103081524800_RSTB20250275C94","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1038\/s41467-022-33252-6","article-title":"Small soluble \u03b1-synuclein aggregates are the toxic species in Parkinson's disease","volume":"13","author":"Emin","year":"2022","journal-title":"Nat. Commun."},{"key":"2026100103081524800_RSTB20250275C95","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that \u03b1-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026100103081524800_RSTB20250275C96","doi-asserted-by":"crossref","first-page":"e38545","DOI":"10.1371\/journal.pone.0038545","article-title":"The role of alpha-synuclein oligomerization and aggregation in cellular and animal models of Parkinson's disease","volume":"7","author":"Wan","year":"2012","journal-title":"PLoS ONE"},{"key":"2026100103081524800_RSTB20250275C97","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous \u03b1-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron"},{"key":"2026100103081524800_RSTB20250275C98","doi-asserted-by":"crossref","first-page":"20 051","DOI":"10.1073\/pnas.0908005106","article-title":"Exogenous \u03b1-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells","volume":"106","author":"Luk","year":"2009","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026100103081524800_RSTB20250275C99","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1523\/JNEUROSCI.1788-16.2017","article-title":"Prying into the prion hypothesis for Parkinson's disease","volume":"37","author":"Brundin","year":"2017","journal-title":"J. Neurosci."},{"key":"2026100103081524800_RSTB20250275C100","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11910-014-0495-z","article-title":"Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies","volume":"14","author":"Goedert","year":"2014","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"2026100103081524800_RSTB20250275C101","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.arr.2019.01.012","article-title":"The prion-like spreading of \u03b1-synuclein: from in vitro to in vivo models of Parkinson's disease","volume":"50","author":"Vargas","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"2026100103081524800_RSTB20250275C102","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles","volume":"30","author":"Colombo","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"2026100103081524800_RSTB20250275C103","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","article-title":"Cell-produced \u03b1-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival","volume":"30","author":"Emmanouilidou","year":"2010","journal-title":"J. Neurosci."},{"key":"2026100103081524800_RSTB20250275C104","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00441-017-2775-9","article-title":"Release and uptake of pathologic alpha-synuclein","volume":"373","author":"Grozdanov","year":"2018","journal-title":"Cell Tissue Res."},{"key":"2026100103081524800_RSTB20250275C105","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41580-019-0101-y","article-title":"The proteostasis network and its decline in ageing","volume":"20","author":"Hipp","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2026100103081524800_RSTB20250275C106","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tcb.2014.05.003","article-title":"Proteostasis impairment in protein-misfolding and -aggregation diseases","volume":"24","author":"Hipp","year":"2014","journal-title":"Trends Cell Biol."},{"key":"2026100103081524800_RSTB20250275C107","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1083\/jcb.201709072","article-title":"Pathways of cellular proteostasis in aging and disease","volume":"217","author":"Klaips","year":"2018","journal-title":"J. Cell Biol."},{"key":"2026100103081524800_RSTB20250275C108","doi-asserted-by":"crossref","first-page":"168615","DOI":"10.1016\/j.jmb.2024.168615","article-title":"Interplay of proteostasis capacity and protein aggregation: implications for cellular function and disease","volume":"436","author":"Hipp","year":"2024","journal-title":"J. Mol. Biol."},{"key":"2026100103081524800_RSTB20250275C109","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ajhg.2011.08.009","article-title":"Translation initiator EIF4G1 mutations in familial Parkinson disease","volume":"89","author":"Chartier-Harlin","year":"2011","journal-title":"Am. Hum. Genet."},{"key":"2026100103081524800_RSTB20250275C110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00401-012-1059-4","article-title":"Sequence variants in eukaryotic translation initiation factor 4-gamma (eIF4G1) are associated with Lewy body dementia","volume":"125","author":"Fujioka","year":"2013","journal-title":"Acta Neuropathol."},{"key":"2026100103081524800_RSTB20250275C111","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1212\/WNL.0b013e31828727d4","article-title":"Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease","volume":"80","author":"Nuytemans","year":"2013","journal-title":"Neurology"},{"key":"2026100103081524800_RSTB20250275C112","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0959-440X(03)00009-5","article-title":"Eukaryotic translation initiation factors and regulators","volume":"13","author":"Sonenberg","year":"2003","journal-title":"Curr. Opin. Struct. Biol."},{"key":"2026100103081524800_RSTB20250275C113","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neuron.2014.11.027","article-title":"Parkinson's disease genes VPS35 and EIF4G1 interact genetically and converge on \u03b1-synuclein","volume":"85","author":"Dhungel","year":"2015","journal-title":"Neuron"},{"key":"2026100103081524800_RSTB20250275C114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuron.2014.12.045","article-title":"Linking the VPS35 and EIF4G1 pathways in Parkinson's disease","volume":"85","author":"Ross","year":"2015","journal-title":"Neuron"},{"key":"2026100103081524800_RSTB20250275C115","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.stem.2020.08.002","article-title":"Defects in mRNA translation in LRRK2-mutant hiPSC-derived dopaminergic neurons lead to dysregulated calcium homeostasis","volume":"27","author":"Kim","year":"2020","journal-title":"Cell Stem Cell"},{"key":"2026100103081524800_RSTB20250275C116","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.3390\/ijms25042393","article-title":"Protein translation in the pathogenesis of Parkinson's disease","volume":"25","author":"Ashraf","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"2026100103081524800_RSTB20250275C117","doi-asserted-by":"crossref","first-page":"14 217","DOI":"10.1096\/fj.202001046R","article-title":"Protein synthesis is suppressed in sporadic and familial Parkinson's disease by LRRK2","volume":"34","author":"Deshpande","year":"2020","journal-title":"FASEB J."},{"key":"2026100103081524800_RSTB20250275C118","doi-asserted-by":"crossref","first-page":"ENEURO.0310","DOI":"10.1523\/ENEURO.0310-21.2021","article-title":"Dysregulated mRNA translation in the G2019S LRRK2 and LRRK2 knock-out mouse brains","volume":"8","author":"Kim","year":"2021","journal-title":"Eneuro"},{"key":"2026100103081524800_RSTB20250275C119","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41531-023-00460-w","article-title":"Regulators of proteostasis are translationally repressed in fibroblasts from patients with sporadic and LRRK2-G2019S Parkinson's disease","volume":"9","author":"Flinkman","year":"2023","journal-title":"NPJ Parkinson's Dis."},{"key":"2026100103081524800_RSTB20250275C120","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cell.2014.01.064","article-title":"Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease","volume":"157","author":"Martin","year":"2014","journal-title":"Cell"},{"key":"2026100103081524800_RSTB20250275C121","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/jnc.12798","article-title":"Differential protein\u2013protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathways","volume":"131","author":"Reyniers","year":"2014","journal-title":"J. Neurochem."},{"key":"2026100103081524800_RSTB20250275C122","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.cell.2022.05.008","article-title":"The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability","volume":"185","author":"Hallacli","year":"2022","journal-title":"Cell"},{"key":"2026100103081524800_RSTB20250275C123","doi-asserted-by":"crossref","first-page":"a012286","DOI":"10.1101\/cshperspect.a012286","article-title":"P-bodies and stress granules: possible roles in the control of translation and mRNA degradation","volume":"4","author":"Decker","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"2026100103081524800_RSTB20250275C124","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1021\/acs.biochem.7b01162","article-title":"P-bodies: composition, properties, and functions","volume":"57","author":"Luo","year":"2018","journal-title":"Biochemistry"},{"key":"2026100103081524800_RSTB20250275C125","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3390\/biology10050384","article-title":"The unfolded protein response: an overview","volume":"10","author":"Read","year":"2021","journal-title":"Biology"},{"key":"2026100103081524800_RSTB20250275C126","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","article-title":"Mechanisms, regulation and functions of the unfolded protein response","volume":"21","author":"Hetz","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2026100103081524800_RSTB20250275C127","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.tibs.2021.09.001","article-title":"Canary in a coal mine: collided ribosomes as sensors of cellular conditions","volume":"47","author":"Kim","year":"2022","journal-title":"Trends Biochem. Sci."},{"key":"2026100103081524800_RSTB20250275C128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-016-8417-7","article-title":"mTOR signaling in Parkinson's disease","volume":"19","author":"Lan","year":"2017","journal-title":"Neuromol. Med."},{"key":"2026100103081524800_RSTB20250275C129","doi-asserted-by":"crossref","first-page":"eadd0499","DOI":"10.1126\/scitranslmed.add0499","article-title":"Enhanced mTORC1 signaling and protein synthesis in pathologic \u03b1-synuclein cellular and animal models of Parkinson's disease","volume":"15","author":"Khan","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"2026100103081524800_RSTB20250275C130","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature10317","article-title":"Molecular chaperones in protein folding and proteostasis","volume":"475","author":"Hartl","year":"2011","journal-title":"Nature"},{"key":"2026100103081524800_RSTB20250275C131","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-019-1808-9","article-title":"Regulation of \u03b1-synuclein by chaperones in mammalian cells","volume":"577","author":"Burmann","year":"2020","journal-title":"Nature"},{"key":"2026100103081524800_RSTB20250275C132","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1038\/emboj.2009.298","article-title":"Chaperone proteostasis in Parkinson's disease: stabilization of the Hsp70\/\u03b1-synuclein complex by Hip","volume":"28","author":"Roodveldt","year":"2009","journal-title":"EMBO J."},{"key":"2026100103081524800_RSTB20250275C133","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.molcel.2015.07.012","article-title":"Human Hsp70 disaggregase reverses Parkinson's-linked \u03b1-synuclein amyloid fibrils","volume":"59","author":"Gao","year":"2015","journal-title":"Mol. Cell"},{"key":"2026100103081524800_RSTB20250275C134","doi-asserted-by":"crossref","first-page":"34 690","DOI":"10.1074\/jbc.M111.261321","article-title":"Hsc70 Protein interaction with soluble and fibrillar \u03b1-synuclein","volume":"286","author":"Pemberton","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2026100103081524800_RSTB20250275C135","doi-asserted-by":"crossref","first-page":"105453","DOI":"10.1016\/j.neuint.2022.105453","article-title":"Potential application of heat shock proteins as therapeutic targets in Parkinson's disease","volume":"162","author":"Guo","year":"2023","journal-title":"Neurochem. Int."},{"key":"2026100103081524800_RSTB20250275C136","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.celrep.2014.09.042","article-title":"A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease","volume":"9","author":"Brehme","year":"2014","journal-title":"Cell Rep."},{"key":"2026100103081524800_RSTB20250275C137","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/1756285613493469","article-title":"Targeting heat shock proteins to modulate \u03b1-synuclein toxicity","volume":"7","author":"Jones","year":"2014","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"2026100103081524800_RSTB20250275C138","doi-asserted-by":"crossref","first-page":"25 497","DOI":"10.1074\/jbc.M400255200","article-title":"Hsp70 Reduces \u03b1-synuclein aggregation and toxicity","volume":"279","author":"Klucken","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2026100103081524800_RSTB20250275C139","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bbrc.2006.10.085","article-title":"Small heat shock proteins protect against \u03b1-synuclein-induced toxicity and aggregation","volume":"351","author":"Outeiro","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2026100103081524800_RSTB20250275C140","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1126\/science.1067389","article-title":"Chaperone suppression of \u03b1-synuclein toxicity in a Drosophila model for Parkinson's disease","volume":"295","author":"Auluck","year":"2002","journal-title":"Science"},{"key":"2026100103081524800_RSTB20250275C141","doi-asserted-by":"crossref","first-page":"24 310","DOI":"10.1073\/pnas.1903268116","article-title":"Hsp110 mitigates \u03b1-synuclein pathology in vivo","volume":"116","author":"Taguchi","year":"2019","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026100103081524800_RSTB20250275C142","doi-asserted-by":"crossref","first-page":"9039","DOI":"10.1038\/s41598-017-08324-z","article-title":"The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress \u03b1-synuclein aggregation","volume":"7","author":"Aprile","year":"2017","journal-title":"Sci. Rep."},{"key":"2026100103081524800_RSTB20250275C143","doi-asserted-by":"crossref","first-page":"eabo1997","DOI":"10.1126\/scitranslmed.abo1997","article-title":"Single-cell transcriptomic and proteomic analysis of Parkinson's disease brains","volume":"16","author":"Zhu","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"2026100103081524800_RSTB20250275C144","doi-asserted-by":"crossref","first-page":"e107568","DOI":"10.15252\/embj.2020107568","article-title":"The cellular modifier MOAG-4\/SERF drives amyloid formation through charge complementation","volume":"40","author":"Pras","year":"2021","journal-title":"EMBO J."},{"key":"2026100103081524800_RSTB20250275C145","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cell.2010.07.020","article-title":"Identification of MOAG-4\/SERF as a regulator of age-related proteotoxicity","volume":"142","author":"van Ham","year":"2010","journal-title":"Cell"},{"key":"2026100103081524800_RSTB20250275C146","doi-asserted-by":"crossref","first-page":"8269","DOI":"10.1074\/jbc.M116.764886","article-title":"MOAG-4 promotes the aggregation of \u03b1-synuclein by competing with self-protective electrostatic interactions","volume":"292","author":"Yoshimura","year":"2017","journal-title":"J. Biol. Chem."},{"key":"2026100103081524800_RSTB20250275C147","doi-asserted-by":"crossref","first-page":"105667","DOI":"10.1016\/j.jbc.2024.105667","article-title":"The disordered protein SERF promotes \u03b1-synuclein aggregation through liquid\u2013liquid phase separation","volume":"300","author":"Liu","year":"2024","journal-title":"J. Biol. Chem."},{"key":"2026100103081524800_RSTB20250275C148","doi-asserted-by":"crossref","first-page":"e2409139121","DOI":"10.1073\/pnas.2409139121","article-title":"Molecular insights into the interaction between a disordered protein and a folded RNA","volume":"121","author":"Mitra","year":"2024","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026100103081524800_RSTB20250275C149","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1111\/febs.16555","article-title":"SERF, a family of tiny highly conserved, highly charged proteins with enigmatic functions","volume":"290","author":"Sahoo","year":"2023","journal-title":"FEBS J."},{"key":"2026100103081524800_RSTB20250275C150","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.biocel.2016.07.019","article-title":"The ubiquitin-proteasome system and autophagy: coordinated and independent activities","volume":"79","author":"Cohen-Kaplan","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2026100103081524800_RSTB20250275C151","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3390\/cells8060565","article-title":"Autophagy in synucleinopathy: the overwhelmed and defective machinery","volume":"8","author":"Arotcarena","year":"2019","journal-title":"Cells"},{"key":"2026100103081524800_RSTB20250275C152","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40478-020-0894-0","article-title":"Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by \u03b1-synuclein","volume":"8","author":"McKinnon","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"2026100103081524800_RSTB20250275C153","doi-asserted-by":"crossref","first-page":"e14128","DOI":"10.1111\/acel.14128","article-title":"Inhibition of 26Sproteasome activity by \u03b1-synuclein is mediated by the proteasomal chaperone Rpn14\/PAAF1","volume":"23","author":"Galka","year":"2024","journal-title":"Aging Cell"},{"key":"2026100103081524800_RSTB20250275C154","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.nbd.2009.05.023","article-title":"Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions","volume":"35","author":"Chu","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"2026100103081524800_RSTB20250275C155","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s00702-004-0212-1","article-title":"Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion\/cellular matrix and vesicle trafficking genes","volume":"111","author":"Gr\u00fcnblatt","year":"2004","journal-title":"J. Neural Transm."},{"key":"2026100103081524800_RSTB20250275C156","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-3940(02)00296-3","article-title":"Selective loss of 20S proteasome \u03b1-subunits in the substantia nigra pars compacta in Parkinson's disease","volume":"326","author":"McNaught","year":"2002","journal-title":"Neurosci. Lett."},{"key":"2026100103081524800_RSTB20250275C157","doi-asserted-by":"crossref","first-page":"12 924","DOI":"10.1074\/jbc.M306390200","article-title":"Proteasomal inhibition by \u03b1-synuclein filaments and oligomers","volume":"279","author":"Lindersson","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2026100103081524800_RSTB20250275C158","doi-asserted-by":"crossref","first-page":"20 288","DOI":"10.1074\/jbc.M710560200","article-title":"\u03b1-synuclein protofibrils inhibit 26 S proteasome-mediated protein degradation","volume":"283","author":"Zhang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"2026100103081524800_RSTB20250275C159","first-page":"777","article-title":"Dopamine-modified \u03b1-synuclein blocks chaperone-mediated autophagy","volume":"118","author":"Martinez-Vicente","year":"2008","journal-title":"J. Clin. Invest."},{"key":"2026100103081524800_RSTB20250275C160","doi-asserted-by":"crossref","first-page":"a016857","DOI":"10.1101\/cshperspect.a016857","article-title":"The complex ultrastructure of the endolysosomal system","volume":"6","author":"Klumperman","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"2026100103081524800_RSTB20250275C161","doi-asserted-by":"crossref","first-page":"20220517","DOI":"10.1098\/rstb.2022.0517","article-title":"Common genetic risk for Parkinson's disease and dysfunction of the endo-lysosomal system","volume":"379","author":"Bhore","year":"2024","journal-title":"Phil. Trans. R. Soc. B"},{"key":"2026100103081524800_RSTB20250275C162","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1212\/01.wnl.0000327823.81237.d1","article-title":"Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset","volume":"72","author":"Nichols","year":"2009","journal-title":"Neurology"},{"key":"2026100103081524800_RSTB20250275C163","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neulet.2014.06.023","article-title":"Identification of p.Gln858* in ATP13A2 in two EOPD patients and presentation of their clinical features","volume":"577","author":"Malakouti-Nejad","year":"2014","journal-title":"Neurosci. Lett."},{"key":"2026100103081524800_RSTB20250275C164","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.3390\/ijms22052689","article-title":"ATP13A2 Regulates cellular alpha-synuclein multimerization, membrane association, and externalization","volume":"22","author":"Si","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"2026100103081524800_RSTB20250275C165","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40035-025-00486-5","article-title":"A genome-wide RNA interference screening reveals protectiveness of SNX5 knockdown in a Parkinson's disease cell model","volume":"14","author":"H\u00f6llerhage","year":"2025","journal-title":"Trans. Neurodegener."},{"key":"2026100103081524800_RSTB20250275C166","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41598-018-35811-8","article-title":"Extracellular aggregated alpha synuclein primarily triggers lysosomal dysfunction in neural cells prevented by trehalose","volume":"9","author":"Hoffmann","year":"2019","journal-title":"Sci. Rep."},{"key":"2026100103081524800_RSTB20250275C167","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3390\/biom11091333","article-title":"Alpha-synuclein and the endolysosomal system in Parkinson's disease: guilty by association","volume":"11","author":"Teixeira","year":"2021","journal-title":"Biomolecules"},{"key":"2026100103081524800_RSTB20250275C168","doi-asserted-by":"crossref","first-page":"9611","DOI":"10.1073\/pnas.1112368109","article-title":"Loss of P-type ATPase ATP13A2\/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration","volume":"109","author":"Dehay","year":"2012","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026100103081524800_RSTB20250275C169","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1002\/pmic.200800109","article-title":"Proteomic profiling of exosomes: current perspectives","volume":"8","author":"Simpson","year":"2008","journal-title":"Proteomics"},{"key":"2026100103081524800_RSTB20250275C170","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.nbd.2011.01.029","article-title":"Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission","volume":"42","author":"Alvarez-Erviti","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"2026100103081524800_RSTB20250275C171","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/15548627.2017.1395992","article-title":"Autophagy inhibition promotes SNCA\/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype","volume":"14","author":"Minakaki","year":"2018","journal-title":"Autophagy"},{"key":"2026100103081524800_RSTB20250275C172","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1038\/s41467-022-32625-1","article-title":"Lysosomal exocytosis releases pathogenic \u03b1-synuclein species from neurons in synucleinopathy models","volume":"13","author":"Xie","year":"2022","journal-title":"Nat. Commun."},{"key":"2026100103081524800_RSTB20250275C173","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00018-024-05419-5","article-title":"Lysosomal dysfunction in \u03b1-synuclein pathology: molecular mechanisms and therapeutic strategies","volume":"81","author":"Dai","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"2026100103081524800_RSTB20250275C174","doi-asserted-by":"crossref","first-page":"E1817","DOI":"10.1073\/pnas.1305623110","article-title":"TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity","volume":"110","author":"Decressac","year":"2013","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026100103081524800_RSTB20250275C175","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1126\/science.aag3048","article-title":"Lysosome activation clears aggregates and enhances quiescent neural stem cell activation during aging","volume":"359","author":"Leeman","year":"2018","journal-title":"Science"},{"key":"2026100103081524800_RSTB20250275C176","doi-asserted-by":"crossref","first-page":"681369","DOI":"10.3389\/fneur.2021.681369","article-title":"Targeting of lysosomal pathway genes for Parkinson's disease modification: insights from cellular and animal models","volume":"12","author":"Abe","year":"2021","journal-title":"Front. Neurol."},{"key":"2026100103081524800_RSTB20250275C177","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40035-023-00363-z","article-title":"Reciprocal effects of alpha-synuclein aggregation and lysosomal homeostasis in synucleinopathy models","volume":"12","author":"Drobny","year":"2023","journal-title":"Trans. Neurodegener."},{"key":"2026100103081524800_RSTB20250275C178","doi-asserted-by":"crossref","first-page":"a008888","DOI":"10.1101\/cshperspect.a008888","article-title":"Genetics of Parkinson's disease","volume":"2","author":"Klein","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2026100103081524800_RSTB20250275C179","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tins.2004.06.005","article-title":"Energetic basis of brain activity: implications for neuroimaging","volume":"27","author":"Shulman","year":"2004","journal-title":"Trends Neurosci."},{"key":"2026100103081524800_RSTB20250275C180","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1042\/BST20240261","article-title":"Interplay of mitochondrial calcium signalling and reactive oxygen species production in the brain","volume":"52","author":"Angelova","year":"2024","journal-title":"Biochem. Soc. Trans."},{"key":"2026100103081524800_RSTB20250275C181","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3390\/cells13070648","article-title":"Mitochondrial permeability transition, cell death and neurodegeneration","volume":"13","author":"Baev","year":"2024","journal-title":"Cells"},{"key":"2026100103081524800_RSTB20250275C182","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.neuron.2015.03.035","article-title":"A cellular perspective on brain energy metabolism and functional imaging","volume":"86","author":"Allaman","year":"2015","journal-title":"Neuron"},{"key":"2026100103081524800_RSTB20250275C183","doi-asserted-by":"crossref","first-page":"106889","DOI":"10.1016\/j.nbd.2025.106889","article-title":"\u03b1-synuclein pathology and mitochondrial dysfunction: toxic partners in Parkinson's disease","volume":"209","author":"Mingo","year":"2025","journal-title":"Neurobiol. Dis."},{"key":"2026100103081524800_RSTB20250275C184","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"2026100103081524800_RSTB20250275C185","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease","volume":"109","author":"Rocha","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"2026100103081524800_RSTB20250275C186","doi-asserted-by":"crossref","first-page":"a011353","DOI":"10.1101\/cshperspect.a011353","article-title":"Calcium control of neurotransmitter release","volume":"4","author":"Sudhof","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"2026100103081524800_RSTB20250275C187","doi-asserted-by":"crossref","first-page":"17 914","DOI":"10.1074\/jbc.M111.302794","article-title":"\u03b1-synuclein controls mitochondrial calcium homeostasis by enhancing endoplasmic reticulum-mitochondria interactions","volume":"287","author":"Cal\u00ec","year":"2012","journal-title":"J. Biol. Chem."},{"key":"2026100103081524800_RSTB20250275C188","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1523\/JNEUROSCI.2507-13.2014","article-title":"\u03b1-synuclein is localized to mitochondria-associated ER membranes","volume":"34","author":"Guardia-Laguarta","year":"2014","journal-title":"J. Neurosci."},{"key":"2026100103081524800_RSTB20250275C189","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00401-017-1704-z","article-title":"\u03b1-synuclein binds to the ER\u2013mitochondria tethering protein VAPB to disrupt Ca2+ homeostasis and mitochondrial ATP production","volume":"134","author":"Paillusson","year":"2017","journal-title":"Acta Neuropathol."},{"key":"2026100103081524800_RSTB20250275C190","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1038\/s41467-018-04422-2","article-title":"\u03b1-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease","volume":"9","author":"Ludtmann","year":"2018","journal-title":"Nat. Commun."},{"key":"2026100103081524800_RSTB20250275C191","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neulet.2010.09.061","article-title":"Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo","volume":"486","author":"Chinta","year":"2010","journal-title":"Neurosci. Lett."},{"key":"2026100103081524800_RSTB20250275C192","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M710012200","article-title":"Mitochondrial import and accumulation of \u03b1-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain","volume":"283","author":"Devi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"2026100103081524800_RSTB20250275C193","doi-asserted-by":"crossref","first-page":"20 710","DOI":"10.1074\/jbc.M110.213538","article-title":"Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein \u03b1-synuclein","volume":"286","author":"Nakamura","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2026100103081524800_RSTB20250275C194","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.bbabio.2009.01.019","article-title":"Mitochondrial calcium as a key regulator of mitochondrial ATP production in mammalian cells","volume":"1787","author":"Griffiths","year":"2009","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"2026100103081524800_RSTB20250275C195","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1038\/s41467-024-47027-8","article-title":"Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology","volume":"15","author":"Goralski","year":"2024","journal-title":"Nat. Commun."},{"key":"2026100103081524800_RSTB20250275C196","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13024-024-00756-2","article-title":"\u03b1-synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson's disease","volume":"19","author":"Geibl","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"2026100103081524800_RSTB20250275C197","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/s41593-022-01140-3","article-title":"Pathological structural conversion of \u03b1-synuclein at the mitochondria induces neuronal toxicity","volume":"25","author":"Choi","year":"2022","journal-title":"Nat. Neurosci."},{"key":"2026100103081524800_RSTB20250275C198","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11910-019-0925-z","article-title":"Unbiased screens for modifiers of alpha-synuclein toxicity","volume":"19","author":"H\u00f6llerhage","year":"2019","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"2026100103081524800_RSTB20250275C199","doi-asserted-by":"crossref","first-page":"14 912","DOI":"10.1073\/pnas.1203083109","article-title":"Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation","volume":"109","author":"van der Goot","year":"2012","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026100103081524800_RSTB20250275C200","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"2026100103081524800_RSTB20250275C201","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"2026100103081524800_RSTB20250275C202","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.bcp.2012.12.014","article-title":"Kynurenic acid as an antagonist of \u03b17 nicotinic acetylcholine receptors in the brain: facts and challenges","volume":"85","author":"Albuquerque","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"2026100103081524800_RSTB20250275C203","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neubiorev.2025.106310","article-title":"Metabolomics: potential non-protein biomarker candidates of Parkinson's disease","volume":"176","author":"Kaleta","year":"2025","journal-title":"Neurosci. Biobehav. Rev."},{"key":"2026100103081524800_RSTB20250275C204","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41531-025-00964-7","article-title":"Parkinson's disease is characterized by vitamin B6-dependent inflammatory kynurenine pathway dysfunction","volume":"11","author":"Wilson","year":"2025","journal-title":"NPJ Parkinson's Dis."},{"key":"2026100103081524800_RSTB20250275C205","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/jnc.14843","article-title":"Age- and disease-specific changes of the kynurenine pathway in Parkinson's and alzheimer's disease","volume":"151","author":"Sorgdrager","year":"2019","journal-title":"J. Neurochem."},{"key":"2026100103081524800_RSTB20250275C206","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/mds.28202","article-title":"Tryptophan metabolites are associated with symptoms and nigral pathology in Parkinson's disease","volume":"35","author":"Heilman","year":"2020","journal-title":"Mov. Disord."},{"key":"2026100103081524800_RSTB20250275C207","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3389\/fimmu.2017.01360","article-title":"Indoleamine 2,3-dioxygenase and tolerance: where are we now?","volume":"8","author":"Mellor","year":"2017","journal-title":"Front. Immunol."},{"key":"2026100103081524800_RSTB20250275C208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/IJTR.S8158","article-title":"Quinolinic acid, an endogenous molecule combining excitotoxicity, oxidative stress and other toxic mechanisms","volume":"5","author":"La Cruz","year":"2012","journal-title":"Int. J. Tryptophan Res."},{"key":"2026100103081524800_RSTB20250275C209","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/metabo15030210","article-title":"Diverse physiological roles of kynurenine pathway metabolites: updated implications for health and disease","volume":"15","author":"Wang","year":"2025","journal-title":"Metabolites"},{"key":"2026100103081524800_RSTB20250275C210","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/jnen\/nly024","article-title":"Increased oxidative stress exacerbates \u03b1-synuclein aggregation in vivo","volume":"77","author":"Scudamore","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2026100103081524800_RSTB20250275C211","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3390\/antiox11122466","article-title":"Neuronal oxidative stress promotes \u03b1-synuclein aggregation in vivo","volume":"11","author":"Won","year":"2022","journal-title":"Antioxidants"},{"key":"2026100103081524800_RSTB20250275C212","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1016\/j.jmb.2018.08.002","article-title":"Quinolinic acid amyloid-like fibrillar assemblies seed \u03b1-synuclein aggregation","volume":"430","author":"Tavassoly","year":"2018","journal-title":"J. Mol. Biol."},{"key":"2026100103081524800_RSTB20250275C213","doi-asserted-by":"crossref","first-page":"213.e3","DOI":"10.1016\/j.neurobiolaging.2016.06.001","article-title":"Genome-wide assessment of Parkinson's disease in a southern Spanish population","volume":"45","author":"Bandr\u00e9s-Ciga","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"2026100103081524800_RSTB20250275C214","doi-asserted-by":"crossref","first-page":"e1002548","DOI":"10.1371\/journal.pgen.1002548","article-title":"Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database","volume":"8","author":"Lill","year":"2012","journal-title":"PLoS Genet."},{"key":"2026100103081524800_RSTB20250275C215","first-page":"3489638","article-title":"Polymorphisms of ACMSD-TMEM163, MCCC1, and BCKDK-STX1B are not associated with Parkinson's disease in Taiwan","volume":"2019","author":"Chang","year":"2019","journal-title":"Parkinson's Dis."},{"key":"2026100103081524800_RSTB20250275C216","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neulet.2019.03.019","article-title":"Association of three candidate genetic variants in ACMSD\/TMEM163, GPNMB and BCKDK \/STX1B with sporadic Parkinson's disease in Han Chinese","volume":"703","author":"Wang","year":"2019","journal-title":"Neurosci. Lett."},{"key":"2026100103081524800_RSTB20250275C217","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41531-025-00940-1","article-title":"A zebrafish model of acmsd deficiency does not support a prominent role for ACMSD in Parkinson's disease","volume":"11","author":"Fargher","year":"2025","journal-title":"NPJ Parkinson's Dis."},{"key":"2026100103081524800_RSTB20250275C218","doi-asserted-by":"crossref","first-page":"117864692097265","DOI":"10.1177\/1178646920972657","article-title":"The effect of tryptophan 2,3-dioxygenase inhibition on kynurenine metabolism and cognitive function in the APP23 mouse model of Alzheimer's Disease","volume":"13","author":"Sorgdrager","year":"2020","journal-title":"Int. J. Tryptophan. Res."},{"key":"2026100103081524800_RSTB20250275C219","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1111\/febs.15721","article-title":"Pharmacological validation of TDO as a target for Parkinson's disease","volume":"288","author":"Perez-Pardo","year":"2021","journal-title":"FEBS J."},{"key":"2026100103081524800_RSTB20250275C220","doi-asserted-by":"crossref","first-page":"a041646","DOI":"10.1101\/cshperspect.a041646","article-title":"Lipid alterations and pathogenic roles in synucleinopathies","author":"Area-G\u00f3mez","year":"2025","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2026100103081524800_RSTB20250275C221","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00401-020-02177-z","article-title":"Vesicle trafficking and lipid metabolism in synucleinopathy","volume":"141","author":"Fanning","year":"2021","journal-title":"Acta Neuropathol."},{"key":"2026100103081524800_RSTB20250275C222","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00401-023-02601-0","article-title":"More than meets the eye in Parkinson's disease and other synucleinopathies: from proteinopathy to lipidopathy","volume":"146","author":"Flores-Leon","year":"2023","journal-title":"Acta Neuropathol."},{"key":"2026100103081524800_RSTB20250275C223","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/mds.27659","article-title":"Parkinson's disease age at onset genome-wide association study: defining heritability, genetic loci, and \u03b1-synuclein mechanisms","volume":"34","author":"Blauwendraat","year":"2019","journal-title":"Mov. Disord."},{"key":"2026100103081524800_RSTB20250275C224","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/ng.3955","article-title":"A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci","volume":"49","author":"Chang","year":"2017","journal-title":"Nat. Genet."},{"key":"2026100103081524800_RSTB20250275C225","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.wnl.0000276989.17578.02","article-title":"Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease","volume":"69","author":"Clark","year":"2007","journal-title":"Neurology"},{"key":"2026100103081524800_RSTB20250275C226","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1212\/01.wnl.0000230215.41296.18","article-title":"Glucocerebrosidase mutations are an important risk factor for Lewy body disorders","volume":"67","author":"Goker-Alpan","year":"2006","journal-title":"Neurology"},{"key":"2026100103081524800_RSTB20250275C227","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41588-023-01584-8","article-title":"Multi-ancestry genome-wide association meta-analysis of Parkinson's disease","volume":"56","author":"Kim","year":"2024","journal-title":"Nat. Genet."},{"key":"2026100103081524800_RSTB20250275C228","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ng1826","article-title":"PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron","volume":"38","author":"Morgan","year":"2006","journal-title":"Nat. Genet."},{"key":"2026100103081524800_RSTB20250275C229","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol."},{"key":"2026100103081524800_RSTB20250275C230","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ng.3043","article-title":"Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease","volume":"46","author":"Nalls","year":"2014","journal-title":"Nat. Genet."},{"key":"2026100103081524800_RSTB20250275C231","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/humu.22373","article-title":"Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset parkinsonism","volume":"34","author":"Quadri","year":"2013","journal-title":"Hum. Mutat."},{"key":"2026100103081524800_RSTB20250275C232","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson's disease","volume":"41","author":"Sim\u00f3n-S\u00e1nchez","year":"2009","journal-title":"Nat. Genet."},{"key":"2026100103081524800_RSTB20250275C233","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/ejhg.2010.254","article-title":"Genome-wide association study confirms extant PD risk loci among the Dutch","volume":"19","author":"Sim\u00f3n-S\u00e1nchez","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"2026100103081524800_RSTB20250275C234","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41588-021-00785-3","article-title":"Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture","volume":"53","author":"Chia","year":"2021","journal-title":"Nat. Genet."},{"key":"2026100103081524800_RSTB20250275C235","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jamaneurol.2013.1925","article-title":"A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies","volume":"70","author":"Nalls","year":"2013","journal-title":"JAMA Neurol."},{"key":"2026100103081524800_RSTB20250275C236","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(94)90257-7","article-title":"Apolipoprotein E4 and alzheimer's disease pathology in Lewy body disease and in other \u03b2-amyloid-forming diseases","volume":"343","author":"Pickering-Brown","year":"1994","journal-title":"Lancet"},{"key":"2026100103081524800_RSTB20250275C237","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","article-title":"APOE \u03b54 increases risk for dementia in pure synucleinopathies","volume":"70","author":"Tsuang","year":"2013","journal-title":"JAMA Neurol."},{"key":"2026100103081524800_RSTB20250275C238","doi-asserted-by":"crossref","first-page":"e16441","DOI":"10.1111\/ene.16441","article-title":"Genetic profiles of multiple system atrophy revealed by exome sequencing, long-read sequencing and spinocerebellar ataxia repeat expansion analysis","volume":"31","author":"Li","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"2026100103081524800_RSTB20250275C239","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1212\/WNL.0000000000003221","article-title":"A genome-wide association study in multiple system atrophy","volume":"87","author":"Sailer","year":"2016","journal-title":"Neurology"},{"key":"2026100103081524800_RSTB20250275C240","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1212115","article-title":"Mutations in COQ2 in familial and sporadic multiple-system atrophy","volume":"369","author":"Multiple-System Atrophy Research Collaboration","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"2026100103081524800_RSTB20250275C241","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neulet.2021.135723","article-title":"Investigating ELOVL7 coding variants in multiple system atrophy","volume":"749","author":"Wernick","year":"2021","journal-title":"Neurosci. Lett."},{"issue":"15","key":"2026100103081524800_RSTB20250275C242","article-title":"Lipid dysfunction and pathogenesis of multiple system atrophy","volume":"2","author":"Bleasel","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"2026100103081524800_RSTB20250275C243","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41582-025-01142-2","article-title":"Parkinson disease is a fatty acidopathy","volume":"21","author":"Fanning","year":"2025","journal-title":"Nat. Rev. Neurol."},{"key":"2026100103081524800_RSTB20250275C244","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13195-024-01585-7","article-title":"Plasma lipidomic signatures of dementia with Lewy bodies revealed by machine learning, and compared to alzheimer's disease","volume":"16","author":"Shen","year":"2024","journal-title":"Alzheimer's Res. Ther."},{"key":"2026100103081524800_RSTB20250275C245","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1194\/jlr.M600003-JLR200","article-title":"Interactions between fatty acids and \u03b1-synuclein","volume":"47","author":"L\u00fccke","year":"2006","journal-title":"J. Lipid Res."},{"key":"2026100103081524800_RSTB20250275C246","doi-asserted-by":"crossref","first-page":"41 958","DOI":"10.1074\/jbc.M105022200","article-title":"Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins","volume":"276","author":"Perrin","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2026100103081524800_RSTB20250275C247","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","article-title":"The formation of highly soluble oligomers of-synuclein is regulated by fatty acids and enhanced in Parkinson's disease","volume":"37","author":"Sharon","year":"2003","journal-title":"Neuron"},{"key":"2026100103081524800_RSTB20250275C248","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nchembio.1750","article-title":"Lipid vesicles trigger \u03b1-synuclein aggregation by stimulating primary nucleation","volume":"11","author":"Galvagnion","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"2026100103081524800_RSTB20250275C249","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1021\/acschemneuro.0c00694","article-title":"Polyunsaturated fatty acid modulates membrane-bound monomeric \u03b1-synuclein by modulating membrane microenvironment through preferential interactions","volume":"12","author":"Manna","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"2026100103081524800_RSTB20250275C250","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1140\/epje\/s10189-023-00353-z","article-title":"Docosahexaenoic acid promotes vesicle clustering mediated by alpha-synuclein via electrostatic interaction","volume":"46","author":"Tyoe","year":"2023","journal-title":"Euro. Phys. J. E Soft Matter."},{"key":"2026100103081524800_RSTB20250275C251","doi-asserted-by":"crossref","first-page":"9596","DOI":"10.1073\/pnas.1505953112","article-title":"KTKEGV repeat motifs are key mediators of normal \u03b1-synuclein tetramerization: their mutation causes excess monomers and neurotoxicity","volume":"112","author":"Dettmer","year":"2015","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026100103081524800_RSTB20250275C252","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.molcel.2018.11.028","article-title":"Lipidomic analysis of \u03b1-synuclein neurotoxicity identifies stearoyl CoA desaturase as a target for Parkinson treatment","volume":"73","author":"Fanning","year":"2019","journal-title":"Mol. Cell"},{"key":"2026100103081524800_RSTB20250275C253","doi-asserted-by":"crossref","first-page":"20 760","DOI":"10.1073\/pnas.1903216116","article-title":"Cell models of lipid-rich \u03b1-synuclein aggregation validate known modifiers of \u03b1-synuclein biology and identify stearoyl-CoA desaturase","volume":"116","author":"Imberdis","year":"2019","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026100103081524800_RSTB20250275C254","doi-asserted-by":"crossref","first-page":"e188413","DOI":"10.1172\/jci.insight.188413","article-title":"Stearoyl-CoA desaturase inhibition normalizes brain lipid saturation, \u03b1-synuclein homeostasis, and motor function in mutant Gba1-Parkinson mice","volume":"10","author":"Nuber","year":"2025","journal-title":"JCI Insight"},{"key":"2026100103081524800_RSTB20250275C255","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrm.2017.138","article-title":"Understanding the diversity of membrane lipid composition","volume":"19","author":"Harayama","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2026100103081524800_RSTB20250275C256","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.cell.2019.04.001","article-title":"Neuron-astrocyte metabolic coupling protects against activity-induced fatty acid toxicity","volume":"177","author":"Ioannou","year":"2019","journal-title":"Cell"},{"key":"2026100103081524800_RSTB20250275C257","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","article-title":"Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain","volume":"23","author":"Marschallinger","year":"2020","journal-title":"Nat. Neurosci."},{"key":"2026100103081524800_RSTB20250275C258","doi-asserted-by":"crossref","first-page":"108572","DOI":"10.1016\/j.celrep.2020.108572","article-title":"ApoE4 Impairs neuron-astrocyte coupling of fatty acid metabolism","volume":"34","author":"Qi","year":"2021","journal-title":"Cell Rep."},{"key":"2026100103081524800_RSTB20250275C259","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1083\/jcb.202102136","article-title":"Lipid droplets in the nervous system","volume":"220","author":"Ralhan","year":"2021","journal-title":"J. Cell Biol."},{"key":"2026100103081524800_RSTB20250275C260","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/glia.23978","article-title":"Astrocytes in stress accumulate lipid droplets","volume":"69","author":"Smoli\u010d","year":"2021","journal-title":"Glia"},{"key":"2026100103081524800_RSTB20250275C261","doi-asserted-by":"crossref","first-page":"27 646","DOI":"10.1073\/pnas.2003021117","article-title":"Cell type-specific lipid storage changes in Parkinson's disease patient brains are recapitulated by experimental glycolipid disturbance","volume":"117","author":"Brekk","year":"2020","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026100103081524800_RSTB20250275C262","doi-asserted-by":"crossref","first-page":"e17299","DOI":"10.1371\/journal.pone.0017299","article-title":"Lipid pathway alterations in Parkinson's disease primary visual cortex","volume":"6","author":"Cheng","year":"2011","journal-title":"PLoS ONE"},{"key":"2026100103081524800_RSTB20250275C263","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41531-025-01023-x","article-title":"Lipid profiling of Parkinson's disease brain highlights disruption in lysophosphatidylcholines, and triacylglycerol metabolism","volume":"11","author":"Yilmaz","year":"2025","journal-title":"NPJ Parkinson's Dis."},{"key":"2026100103081524800_RSTB20250275C264","doi-asserted-by":"crossref","first-page":"e0191815","DOI":"10.1371\/journal.pone.0191815","article-title":"Augmented frontal cortex diacylglycerol levels in Parkinson's disease and Lewy body disease","volume":"13","author":"Wood","year":"2018","journal-title":"PLoS ONE"},{"key":"2026100103081524800_RSTB20250275C265","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41531-025-00960-x","article-title":"The role of alpha-synuclein in synucleinopathy: impact on lipid regulation at mitochondria\u2013ER membranes","volume":"11","author":"Barbuti","year":"2025","journal-title":"NPJ Parkinson's Dis."},{"key":"2026100103081524800_RSTB20250275C266","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1093\/brain\/awac176","article-title":"Lipid pathway dysfunction is prevalent in patients with Parkinson's disease","volume":"145","author":"Galper","year":"2022","journal-title":"Brain"},{"key":"2026100103081524800_RSTB20250275C267","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41531-021-00206-6","article-title":"Serum lipid profile among sporadic and familial forms of Parkinson's disease","volume":"7","author":"Mac\u00edas-Garc\u00eda","year":"2021","journal-title":"NPJ Parkinson's Dis."},{"key":"2026100103081524800_RSTB20250275C268","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1007\/s10072-022-06113-9","article-title":"Lower serum triglyceride levels linked to more severe motor performance in Parkinson's disease","volume":"43","author":"Zhang","year":"2022","journal-title":"Neurolog. Sci."},{"key":"2026100103081524800_RSTB20250275C269","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.clnu.2012.02.004","article-title":"Low cardiometabolic risk in Parkinson's disease is independent of nutritional status, body composition and fat distribution","volume":"31","author":"Cereda","year":"2012","journal-title":"Clin. Nutr."},{"key":"2026100103081524800_RSTB20250275C270","doi-asserted-by":"crossref","first-page":"e75743","DOI":"10.1371\/journal.pone.0075743","article-title":"Reduced serum levels of triglyceride, very low density lipoprotein cholesterol and apolipoprotein B in Parkinson's disease patients","volume":"8","author":"Wei","year":"2013","journal-title":"PLoS ONE"},{"issue":"6","key":"2026100103081524800_RSTB20250275C271","doi-asserted-by":"crossref","first-page":"e214033 (1-10)","DOI":"10.1212\/WNL.0000000000214033","article-title":"Metabolic syndrome and incidence of Parkinson disease: a community-based longitudinal study and meta-analysis","volume":"105","author":"Zhang","year":"2025","journal-title":"Neurology"},{"key":"2026100103081524800_RSTB20250275C272","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13195-019-0558-0","article-title":"APOE2 orchestrated differences in transcriptomic and lipidomic profiles of postmortem AD brain","volume":"11","author":"Lefterov","year":"2019","journal-title":"Alzheimer's Res. Ther."},{"issue":"529","key":"2026100103081524800_RSTB20250275C273","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay1809","article-title":"APOE4 exacerbates \u03b1-synuclein pathology and related toxicity independent of amyloid","volume":"12","author":"Zhao","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"2026100103081524800_RSTB20250275C274","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1179\/1743132813Y.0000000277","article-title":"Serum lipid levels are associated with the prevalence but not with the disease progression of multiple system atrophy in a Chinese population","volume":"36","author":"Cao","year":"2014","journal-title":"Neurol. Res."},{"key":"2026100103081524800_RSTB20250275C275","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/mds.22459","article-title":"Serum cholesterol levels and the risk of multiple system atrophy: a case-control study","volume":"24","author":"Lee","year":"2009","journal-title":"Mov. Disord."},{"key":"2026100103081524800_RSTB20250275C276","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-023-01699-3","article-title":"Distinct forebrain regions define a dichotomous astrocytic profile in multiple system atrophy","volume":"12","author":"Schneider","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"2026100103081524800_RSTB20250275C277","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/mds.30248","article-title":"Dysregulation of monounsaturated fatty acids is related to \u03b1-synuclein in multiple system atrophy","volume":"40","author":"Isik","year":"2025","journal-title":"Mov. Disord."},{"key":"2026100103081524800_RSTB20250275C278","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41531-022-00397-6","article-title":"Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology","volume":"8","author":"Navarro-Romero","year":"2022","journal-title":"NPJ Parkinson's Dis."},{"key":"2026100103081524800_RSTB20250275C279","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awp044","article-title":"Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"2026100103081524800_RSTB20250275C280","first-page":"773","article-title":"The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines","volume":"32","author":"Smith","year":"2023","journal-title":"Hum. Mol. Genet."},{"key":"2026100103081524800_RSTB20250275C281","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1093\/brain\/awad150","article-title":"Advances in understanding the function of alpha-synuclein: implications for Parkinson's disease","volume":"146","author":"Calabresi","year":"2023","journal-title":"Brain"},{"issue":"1","key":"2026100103081524800_RSTB20250275C282","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41420-024-02224-8","article-title":"Lipids associated with autophagy: mechanisms and therapeutic targets","volume":"10","author":"Jarocki","year":"2024","journal-title":"Cell death discov."},{"key":"2026100103081524800_RSTB20250275C283","doi-asserted-by":"crossref","first-page":"18 076","DOI":"10.1074\/jbc.RA120.015319","article-title":"A-synuclein facilitates endocytosis by elevating the steady-state levels of phosphatidylinositol 4,5-bisphosphate","volume":"295","author":"Schechter","year":"2020","journal-title":"J. Biol. Chem."},{"key":"2026100103081524800_RSTB20250275C284","doi-asserted-by":"crossref","first-page":"eadj4605","DOI":"10.1126\/sciadv.adj4605","article-title":"Lipid-anchored proteasomes control membrane protein homeostasis","volume":"9","author":"Zhang","year":"2023","journal-title":"Sci. Adv."},{"key":"2026100103081524800_RSTB20250275C285","doi-asserted-by":"crossref","first-page":"e92367","DOI":"10.7554\/eLife.92367","article-title":"Correction: a prebiotic diet modulates microglial states and motor deficits in \u03b1-synuclein overexpressing mice","volume":"12","author":"Abdel-Haq","year":"2023","journal-title":"eLife"},{"key":"2026100103081524800_RSTB20250275C286","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/s12964-025-02393-8","article-title":"Interactions between gut microbiota and Parkinson's disease: the role of tryptophan metabolism","volume":"23","author":"Fan","year":"2025","journal-title":"Cell Commun. Signal."},{"key":"2026100103081524800_RSTB20250275C287","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.3390\/ijms25052915","article-title":"Microbiota, tryptophan and aryl hydrocarbon receptors as the target triad in Parkinson's disease\u2014a narrative review","volume":"25","author":"Iwaniak","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"2026100103081524800_RSTB20250275C288","doi-asserted-by":"crossref","first-page":"1140054","DOI":"10.3389\/fnut.2023.1140054","article-title":"Tryptophan intake, not always the more the better","volume":"10","author":"Hu","year":"2023","journal-title":"Front. Nutr."},{"key":"2026100103081524800_RSTB20250275C289","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.neuropharm.2015.11.015","article-title":"Tryptophan availability for kynurenine pathway metabolism across the life span: control mechanisms and focus on aging, exercise, diet and nutritional supplements","volume":"112","author":"Badawy","year":"2017","journal-title":"Neuropharmacology"},{"key":"2026100103081524800_RSTB20250275C290","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.mad.2016.04.006","article-title":"Caloric restriction alleviates alpha-synuclein toxicity in aged yeast cells by controlling the opposite roles of Tor1 and Sir2 on autophagy","volume":"161","author":"Guedes","year":"2017","journal-title":"Mech. Ageing Dev."},{"key":"2026100103081524800_RSTB20250275C291","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1038\/s41467-025-59249-5","article-title":"Intermittent fasting reduces alpha-synuclein pathology and functional decline in a mouse model of Parkinson's disease","volume":"16","author":"Szeg\u0151","year":"2025","journal-title":"Nat. Commun."},{"key":"2026100103081524800_RSTB20250275C292","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.18632\/aging.101675","article-title":"Caloric restriction rescues yeast cells from alpha-synuclein toxicity through autophagic control of proteostasis","volume":"10","author":"Sampaio-Marques","year":"2018","journal-title":"Aging"},{"key":"2026100103081524800_RSTB20250275C293","doi-asserted-by":"crossref","first-page":"S297","DOI":"10.3233\/JPD-191711","article-title":"Increasing comparability and utility of gut microbiome studies in Parkinson's disease: a systematic review","volume":"9","author":"Boertien","year":"2019","journal-title":"J. Parkinson's Dis."},{"key":"2026100103081524800_RSTB20250275C294","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s11427-016-9001-4","article-title":"Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features","volume":"60","author":"Li","year":"2017","journal-title":"Sci. China Life Sci."},{"key":"2026100103081524800_RSTB20250275C295","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to Parkinson's disease and clinical phenotype","volume":"30","author":"Scheperjans","year":"2015","journal-title":"Mov. Disord."},{"key":"2026100103081524800_RSTB20250275C296","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/WCO.0000000000000389","article-title":"Gut microbiota, 1013 new pieces in the Parkinson's disease puzzle","volume":"29","author":"Scheperjans","year":"2016","journal-title":"Curr. Opin. Neurol."},{"key":"2026100103081524800_RSTB20250275C297","doi-asserted-by":"crossref","first-page":"e848","DOI":"10.1212\/WNL.0000000000013225","article-title":"Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease","volume":"98","author":"Chen","year":"2022","journal-title":"Neurology"},{"key":"2026100103081524800_RSTB20250275C298","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13024-021-00427-6","article-title":"Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease","volume":"16","author":"Aho","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"2026100103081524800_RSTB20250275C299","first-page":"91","article-title":"The role of short-chain fatty acids in health and disease","volume":"121","author":"Tan","year":"2014","journal-title":"Advances in Immunology"},{"key":"2026100103081524800_RSTB20250275C300","doi-asserted-by":"crossref","first-page":"111572","DOI":"10.1016\/j.mce.2022.111572","article-title":"Short chain fatty acids: microbial metabolites for gut-brain axis signalling","volume":"546","author":"O'Riordan","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"2026100103081524800_RSTB20250275C301","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1007\/s12035-021-02375-0","article-title":"Gut microbial metabolites in Parkinson's disease: implications of mitochondrial dysfunction in the pathogenesis and treatment","volume":"58","author":"Liang","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"2026100103081524800_RSTB20250275C302","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.neuroscience.2013.04.037","article-title":"Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson's disease","volume":"246","author":"St Laurent","year":"2013","journal-title":"Neuroscience"},{"key":"2026100103081524800_RSTB20250275C303","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.2337\/db16-0924","article-title":"Butyrate regulates liver mitochondrial function, efficiency, and dynamics in insulin-resistant obese mice","volume":"66","author":"Mollica","year":"2017","journal-title":"Diabetes"},{"key":"2026100103081524800_RSTB20250275C304","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/19490976.2019.1638722","article-title":"Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health","volume":"11","author":"Parker","year":"2020","journal-title":"Gut Microbes"},{"key":"2026100103081524800_RSTB20250275C305","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"2026100103081524800_RSTB20250275C306","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","article-title":"Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway","volume":"70","author":"Sun","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"2026100103081524800_RSTB20250275C307","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1007\/s00415-021-10567-w","article-title":"Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation","volume":"269","author":"Metta","year":"2022","journal-title":"J. Neurol."},{"key":"2026100103081524800_RSTB20250275C308","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3390\/brainsci14111147","article-title":"The impact of probiotics on clinical symptoms and peripheral cytokines levels in Parkinson's disease: preliminary in vivo data","volume":"14","author":"Magistrelli","year":"2024","journal-title":"Brain Sci."},{"key":"2026100103081524800_RSTB20250275C309","doi-asserted-by":"crossref","first-page":"100222","DOI":"10.1016\/j.engmic.2025.100222","article-title":"The role of microbiota dysbiosis in Parkinson's disease: pathophysiology and therapeutic opportunities","volume":"5","author":"Santos","year":"2025","journal-title":"Eng. Microbiol."},{"key":"2026100103081524800_RSTB20250275C310","doi-asserted-by":"crossref","first-page":"9864","DOI":"10.1038\/s41598-025-93737-4","article-title":"Biofilm proficient Bacillus subtilis prevents neurodegeneration in Caenorhabditis elegans Parkinson's disease models via PMK-1\/p38 MAPK and SKN-1\/Nrf2 signaling","volume":"15","author":"Francisco","year":"2025","journal-title":"Sci. Rep."},{"key":"2026100103081524800_RSTB20250275C311","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.celrep.2019.12.078","article-title":"Probiotic Bacillus subtilis protects against \u03b1-synuclein aggregation in C. elegans","volume":"30","author":"Goya","year":"2020","journal-title":"Cell Rep."},{"key":"2026100103081524800_RSTB20250275C312","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41598-024-81020-x","article-title":"Bacterial products initiation of alpha-synuclein pathology: an in vitro study","volume":"14","author":"Ioghen","year":"2024","journal-title":"Sci. Rep."},{"key":"2026100103081524800_RSTB20250275C313","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tma.2025.02.002","article-title":"Curli protein: a potential contributor to \u03b1-synucleopathy in Parkinson's disease","volume":"9","author":"Ghosh","year":"2025","journal-title":"Transl. Med. Aging"},{"key":"2026100103081524800_RSTB20250275C314","doi-asserted-by":"crossref","first-page":"e53111","DOI":"10.7554\/eLife.53111","article-title":"A gut bacterial amyloid promotes \u03b1-synuclein aggregation and motor impairment in mice","volume":"9","author":"Sampson","year":"2020","journal-title":"eLife"},{"key":"2026100103081524800_RSTB20250275C315","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The microbiota-gut-brain axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol. Rev."},{"key":"2026100103081524800_RSTB20250275C316","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13024-020-00368-6","article-title":"Initiation and propagation of \u03b1-synuclein aggregation in the nervous system","volume":"15","author":"Hijaz","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"2026100103081524800_RSTB20250275C317","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.coph.2019.08.001","article-title":"Small talk: microbial metabolites involved in the signaling from microbiota to brain","volume":"48","author":"Caspani","year":"2019","journal-title":"Curr. Opin. Pharmacol."},{"key":"2026100103081524800_RSTB20250275C318","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/advances\/nmz127","article-title":"Tryptophan metabolism: a link between the gut microbiota and brain","volume":"11","author":"Gao","year":"2020","journal-title":"Adv. Nutr."},{"key":"2026100103081524800_RSTB20250275C319","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/imm.12922","article-title":"Inflammation in CNS neurodegenerative diseases","volume":"154","author":"Stephenson","year":"2018","journal-title":"Immunology"},{"key":"2026100103081524800_RSTB20250275C320","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fncel.2018.00247","article-title":"Microglia response during Parkinson's disease: alpha-synuclein intervention","volume":"12","author":"Ferreira","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"2026100103081524800_RSTB20250275C321","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/glia.10148","article-title":"Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system","volume":"40","author":"Husemann","year":"2002","journal-title":"Glia"},{"key":"2026100103081524800_RSTB20250275C322","doi-asserted-by":"crossref","first-page":"e79160","DOI":"10.1371\/journal.pone.0079160","article-title":"Preconditioning of microglia by \u03b1-synuclein strongly affects the response induced by toll-like receptor (TLR) stimulation","volume":"8","author":"Roodveldt","year":"2013","journal-title":"PLoS ONE"},{"key":"2026100103081524800_RSTB20250275C323","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-018-1907-y","article-title":"Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson's disease pathogenesis","volume":"137","author":"Hughes","year":"2019","journal-title":"Acta Neuropathol."},{"key":"2026100103081524800_RSTB20250275C324","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/ncomms2534","article-title":"Neuron-released oligomeric \u03b1-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Nat. Commun."},{"key":"2026100103081524800_RSTB20250275C325","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13024-018-0276-2","article-title":"Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating \u03b1-synuclein transmission and neuroinflammation","volume":"13","author":"Kim","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"2026100103081524800_RSTB20250275C326","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.cmet.2021.07.006","article-title":"Astrocyte-neuron metabolic cooperation shapes brain activity","volume":"33","author":"Bonvento","year":"2021","journal-title":"Cell Metab."},{"key":"2026100103081524800_RSTB20250275C327","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/bpa.12373","article-title":"Exocytosis and spreading of normal and aberrant \u03b1-synuclein","volume":"26","author":"Emmanouilidou","year":"2016","journal-title":"Brain Pathol."},{"key":"2026100103081524800_RSTB20250275C328","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.neurobiolaging.2007.04.006","article-title":"Synuclein activates microglia in a model of Parkinson's disease","volume":"29","author":"Su","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"2026100103081524800_RSTB20250275C329","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.bbrc.2016.09.109","article-title":"Alpha-synuclein activates BV2 microglia dependent on its aggregation state","volume":"479","author":"Hoffmann","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2026100103081524800_RSTB20250275C330","doi-asserted-by":"crossref","first-page":"175966","DOI":"10.1016\/j.ejphar.2023.175966","article-title":"The key roles of reactive oxygen species in microglial inflammatory activation: regulation by endogenous antioxidant system and exogenous sulfur-containing compounds","volume":"956","author":"Fan","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"2026100103081524800_RSTB20250275C331","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3390\/antiox9080743","article-title":"ROS generation in microglia: understanding oxidative stress and inflammation in neurodegenerative disease","volume":"9","author":"Simpson","year":"2020","journal-title":"Antioxidants"},{"key":"2026100103081524800_RSTB20250275C332","doi-asserted-by":"crossref","first-page":"102177","DOI":"10.1016\/j.coi.2022.102177","article-title":"Gut microbiome-mediated regulation of neuroinflammation","volume":"76","author":"Bostick","year":"2022","journal-title":"Curr. Opin. Immunol."},{"key":"2026100103081524800_RSTB20250275C333","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0021-9681(63)90098-5","article-title":"Cohort analysis of Parkinson's syndrome","volume":"16","author":"Poskanzer","year":"1963","journal-title":"J. Chronic. Dis."},{"key":"2026100103081524800_RSTB20250275C334","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00401-023-02562-4","article-title":"Urinary tract infections trigger synucleinopathy via the innate immune response","volume":"145","author":"Peelaerts","year":"2023","journal-title":"Acta Neuropathol."},{"key":"2026100103081524800_RSTB20250275C335","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/bs.pmbts.2019.06.002","article-title":"Can infections trigger alpha-synucleinopathies","volume":"168","author":"Tulisiak","year":"2019","journal-title":"Progress in Molecular Biology and Translational Science"},{"key":"2026100103081524800_RSTB20250275C336","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.bbadis.2008.08.001","article-title":"Viral parkinsonism","volume":"1792","author":"Jang","year":"2009","journal-title":"Biochim. Biophy. Acta"},{"key":"2026100103081524800_RSTB20250275C337","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1021\/acs.jpcb.2c01254","article-title":"Effect of an amyloidogenic SARS-COV-2 protein fragment on \u03b1-synuclein monomers and fibrils","volume":"126","author":"Jana","year":"2022","journal-title":"J. Phys. Chem. B"},{"key":"2026100103081524800_RSTB20250275C338","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1021\/acschemneuro.1c00666","article-title":"Interactions between SARS-CoV-2 N-protein and \u03b1-synuclein accelerate amyloid formation","volume":"13","author":"Semerdzhiev","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"2026100103081524800_RSTB20250275C339","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1021\/acschemneuro.3c00468","article-title":"SARS-CoV-2-mimicking pseudoviral particles accelerate \u03b1-synuclein aggregation in vitro","volume":"15","author":"Zilio","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"2026100103081524800_RSTB20250275C340","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3233\/JPD-240195","article-title":"Infections in the etiology of Parkinson's disease and synucleinopathies: a renewed perspective, mechanistic insights, and therapeutic implications","volume":"14","author":"Mercado","year":"2024","journal-title":"J. Parkinson's Dis."},{"key":"2026100103081524800_RSTB20250275C341","first-page":"1003","article-title":"Neuroinflammation induces neurodegeneration","volume":"1","author":"Kempuraj","year":"2016","journal-title":"J. Neurol. Neurosurg. Spine"},{"key":"2026100103081524800_RSTB20250275C342","doi-asserted-by":"crossref","first-page":"837579","DOI":"10.3389\/ftox.2022.837579","article-title":"Role of environmental toxicants on neurodegenerative disorders","volume":"4","author":"Nabi","year":"2022","journal-title":"Front. Toxicol."},{"key":"2026100103081524800_RSTB20250275C343","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"2026100103081524800_RSTB20250275C344","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0024-3205(86)90037-8","article-title":"Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP","volume":"39","author":"Ramsay","year":"1986","journal-title":"Life Sci."},{"key":"2026100103081524800_RSTB20250275C345","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/WNL.35.7.949","article-title":"Permanent human parkinsonism due to 1-methy 1\u20134-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"35","author":"Ballard","year":"1985","journal-title":"Neurology"},{"key":"2026100103081524800_RSTB20250275C346","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.chemosphere.2025.144348","article-title":"The neurotoxicity of pesticides: implications for Parkinson's disease","volume":"377","author":"Amaral","year":"2025","journal-title":"Chemosphere"},{"key":"2026100103081524800_RSTB20250275C347","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/oem.58.9.582","article-title":"Parkinsonism and occupational exposure to pesticides","volume":"58","author":"Engel","year":"2001","journal-title":"Occup. Environ. Med."},{"key":"2026100103081524800_RSTB20250275C348","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1038\/s41467-023-38215-z","article-title":"A pesticide and iPSC dopaminergic neuron screen identifies and classifies Parkinson-relevant pesticides","volume":"14","author":"Paul","year":"2023","journal-title":"Nat. Commun."}],"container-title":["Philosophical Transactions of the Royal Society B: Biological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/royalsocietypublishing.org\/rstb\/article-pdf\/doi\/10.1098\/rstb.2025.0275\/6168539\/rstb.2025.0275.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/royalsocietypublishing.org\/rstb\/article-pdf\/doi\/10.1098\/rstb.2025.0275\/6168539\/rstb.2025.0275.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:09:00Z","timestamp":1790838540000},"score":1,"resource":{"primary":{"URL":"https:\/\/royalsocietypublishing.org\/rstb\/article\/381\/1960\/20250275\/483478\/Cellular-and-systemic-modifiers-of-alpha-synuclein"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":348,"journal-issue":{"issue":"1960","published-online":{"date-parts":[[2026,10,1]]},"published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1098\/rstb.2025.0275","relation":{},"ISSN":["0962-8436","1471-2970"],"issn-type":[{"value":"0962-8436","type":"print"},{"value":"1471-2970","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"article-number":"20250275"}}